Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q2 2025 Earnings Call Transcript August 5, 2025
Day One Biopharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.29, expectations were $-0.35.
Operator: Greetings, and welcome to the Day One Biopharmaceuticals Q2 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Joey Perrone, Senior Vice President of Finance and...
